Cargando…

Erratum to: Characterizing Benefit from Temozolomide in MGMT Promoter Unmethylated and Methylated Glioblastoma: A Systematic Review and Meta-analysis

Detalles Bibliográficos
Autores principales: Alnahhas, Iyad, Alsawas, Mouaz, Rayi, Appaji, Palmer, Joshua D, Raval, Raju, Ong, Shirley, Giglio, Pierre, Murad, Mohammad Hassan, Puduvalli, Vinay
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8272530/
https://www.ncbi.nlm.nih.gov/pubmed/34258581
http://dx.doi.org/10.1093/noajnl/vdab095
_version_ 1783721239303421952
author Alnahhas, Iyad
Alsawas, Mouaz
Rayi, Appaji
Palmer, Joshua D
Raval, Raju
Ong, Shirley
Giglio, Pierre
Murad, Mohammad Hassan
Puduvalli, Vinay
author_facet Alnahhas, Iyad
Alsawas, Mouaz
Rayi, Appaji
Palmer, Joshua D
Raval, Raju
Ong, Shirley
Giglio, Pierre
Murad, Mohammad Hassan
Puduvalli, Vinay
author_sort Alnahhas, Iyad
collection PubMed
description
format Online
Article
Text
id pubmed-8272530
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-82725302021-07-12 Erratum to: Characterizing Benefit from Temozolomide in MGMT Promoter Unmethylated and Methylated Glioblastoma: A Systematic Review and Meta-analysis Alnahhas, Iyad Alsawas, Mouaz Rayi, Appaji Palmer, Joshua D Raval, Raju Ong, Shirley Giglio, Pierre Murad, Mohammad Hassan Puduvalli, Vinay Neurooncol Adv Erratum Oxford University Press 2021-07-10 /pmc/articles/PMC8272530/ /pubmed/34258581 http://dx.doi.org/10.1093/noajnl/vdab095 Text en © The Author(s) 2021. Published by Oxford University Press, the Society for Neuro-Oncology and the European Association of Neuro-Oncology. https://creativecommons.org/licenses/by-nc/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial License (http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) ), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
spellingShingle Erratum
Alnahhas, Iyad
Alsawas, Mouaz
Rayi, Appaji
Palmer, Joshua D
Raval, Raju
Ong, Shirley
Giglio, Pierre
Murad, Mohammad Hassan
Puduvalli, Vinay
Erratum to: Characterizing Benefit from Temozolomide in MGMT Promoter Unmethylated and Methylated Glioblastoma: A Systematic Review and Meta-analysis
title Erratum to: Characterizing Benefit from Temozolomide in MGMT Promoter Unmethylated and Methylated Glioblastoma: A Systematic Review and Meta-analysis
title_full Erratum to: Characterizing Benefit from Temozolomide in MGMT Promoter Unmethylated and Methylated Glioblastoma: A Systematic Review and Meta-analysis
title_fullStr Erratum to: Characterizing Benefit from Temozolomide in MGMT Promoter Unmethylated and Methylated Glioblastoma: A Systematic Review and Meta-analysis
title_full_unstemmed Erratum to: Characterizing Benefit from Temozolomide in MGMT Promoter Unmethylated and Methylated Glioblastoma: A Systematic Review and Meta-analysis
title_short Erratum to: Characterizing Benefit from Temozolomide in MGMT Promoter Unmethylated and Methylated Glioblastoma: A Systematic Review and Meta-analysis
title_sort erratum to: characterizing benefit from temozolomide in mgmt promoter unmethylated and methylated glioblastoma: a systematic review and meta-analysis
topic Erratum
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8272530/
https://www.ncbi.nlm.nih.gov/pubmed/34258581
http://dx.doi.org/10.1093/noajnl/vdab095
work_keys_str_mv AT alnahhasiyad erratumtocharacterizingbenefitfromtemozolomideinmgmtpromoterunmethylatedandmethylatedglioblastomaasystematicreviewandmetaanalysis
AT alsawasmouaz erratumtocharacterizingbenefitfromtemozolomideinmgmtpromoterunmethylatedandmethylatedglioblastomaasystematicreviewandmetaanalysis
AT rayiappaji erratumtocharacterizingbenefitfromtemozolomideinmgmtpromoterunmethylatedandmethylatedglioblastomaasystematicreviewandmetaanalysis
AT palmerjoshuad erratumtocharacterizingbenefitfromtemozolomideinmgmtpromoterunmethylatedandmethylatedglioblastomaasystematicreviewandmetaanalysis
AT ravalraju erratumtocharacterizingbenefitfromtemozolomideinmgmtpromoterunmethylatedandmethylatedglioblastomaasystematicreviewandmetaanalysis
AT ongshirley erratumtocharacterizingbenefitfromtemozolomideinmgmtpromoterunmethylatedandmethylatedglioblastomaasystematicreviewandmetaanalysis
AT gigliopierre erratumtocharacterizingbenefitfromtemozolomideinmgmtpromoterunmethylatedandmethylatedglioblastomaasystematicreviewandmetaanalysis
AT muradmohammadhassan erratumtocharacterizingbenefitfromtemozolomideinmgmtpromoterunmethylatedandmethylatedglioblastomaasystematicreviewandmetaanalysis
AT puduvallivinay erratumtocharacterizingbenefitfromtemozolomideinmgmtpromoterunmethylatedandmethylatedglioblastomaasystematicreviewandmetaanalysis